首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

1782619

全球家禽疫苗市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Poultry Vaccines Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年08月01日 | 出版商:

Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球家禽疫苗市場規模預計將從 2024 年的 25.6 億美元成長到 2033 年的 50.6 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 7.85%。

隨著全球對健康無病家禽生產的需求持續成長，家禽疫苗市場正經歷顯著成長。疫苗接種是家禽健康管理的重要組成部分，有助於預防禽流感、新城疫和傳染性支氣管炎等疾病的爆發。隨著食品安全意識的不斷提高以及對永續家禽養殖實踐的需求不斷成長，對有效疫苗的需求預計將持續成長。隨著市場的發展，重視研發、產品功效和合規性對於吸引尋求可靠疫苗解決方案的家禽生產商至關重要。

此外，疫苗技術的進步也提升了家禽疫苗的效力。重組疫苗、減毒活疫苗和去活化疫苗等創新技術使製造商能夠開發出保護力更強、副作用更少的產品。水基疫苗和氣霧劑疫苗等給藥系統的整合也日益受到關注，從而提高了給藥效率，並提高了家禽族群的免疫力。隨著家禽疫苗市場的持續成長，對創新和消費者參與的關注將在其未來發展中發揮至關重要的作用。

此外，日益成長的生物安全措施和動物福利趨勢正在影響家禽疫苗市場。隨著生產者尋求將疾病風險降至最低並增強禽群健康，對符合這些目標的疫苗的需求也日益成長。這種轉變促使製造商投資於行銷和分銷策略，以強調疫苗接種在促進家禽健康和生產力方面的優勢。因此，家禽疫苗市場的未來將以對品質、創新和持續改進疫苗接種解決方案的承諾為特徵，以滿足家禽行業不斷變化的需求。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了競爭態勢以及領先公司採用的關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新以及潛在投資領域。本部分將深入探討未來市場發展與成長前景。

區域展望銷售分析
簡介銷售分析
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東非洲各細分市場銷售分析
- 中東非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第10章：家禽疫苗公司的競爭格局

家禽疫苗市場競爭
合作/協作/協議
合併與收購
新產品發布
其他發展

第 11 章：公司簡介

十大公司股票分析
市場集中度
Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Ceva

公司概況
公司收入
產品
最新動態

Zoetis

公司概況
公司收入
產品
最新動態

Elanco

公司概況
公司收入
產品
最新動態

Intervet Inc.

公司概況
公司收入
產品
最新動態

Merck Co. Inc.

公司概況
公司收入
產品
最新動態

Hester Biosciences Limited

公司概況
公司收入
產品
最新動態

Vaxxinova International BV

公司概況
公司收入
產品
最新動態

Venkys India

公司概況
公司收入
產品
最新動態

Calier

公司概況
公司收入
產品
最新動態

KM Biologics

公司概況
公司收入
產品
最新動態

Phibro Animal Health Corporation

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和近期發展取決於可用性，如果是私人公司，則可能不予涵蓋

簡介目錄圖表

Product Code: VMR112110059

Global Poultry Vaccines Market size is anticipated to grow from USD 2.56 Billion in 2024 to USD 5.06 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.85% during the forecast period of 2026 to 2033.

The poultry vaccines market is experiencing significant growth as the demand for healthy and disease-free poultry production continues to rise globally. Vaccination is a crucial component of poultry health management, helping to prevent outbreaks of diseases such as avian influenza, Newcastle disease, and infectious bronchitis. With the increasing awareness of food safety and the need for sustainable poultry farming practices, the demand for effective vaccines is expected to grow. As the market evolves, the emphasis on research and development, product efficacy, and regulatory compliance will be crucial in attracting poultry producers seeking reliable vaccination solutions.

Moreover, advancements in vaccine technology are enhancing the capabilities of poultry vaccines. Innovations such as recombinant vaccines, live attenuated vaccines, and inactivated vaccines are enabling manufacturers to develop products that offer improved protection and reduced side effects. The integration of delivery systems, such as water-based and aerosol vaccines, is also gaining traction, allowing for more efficient administration and better uptake among poultry populations. As the poultry vaccines market continues to grow, the focus on innovation and consumer engagement will play a vital role in shaping its future trajectory.

In addition, the growing trend of biosecurity measures and animal welfare is influencing the poultry vaccines market. As producers seek to minimize disease risks and enhance the health of their flocks, there is a rising demand for vaccines that align with these goals. This shift is prompting manufacturers to invest in marketing and distribution strategies that highlight the benefits of vaccination in promoting poultry health and productivity. The future of the poultry vaccines market is thus characterized by a commitment to quality, innovation, and the continuous improvement of vaccination solutions to meet the evolving needs of the poultry industry.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

Modified or Attenuated (Live)
Inactivated (Killed)
Recombinants

By Dosage Form

Liquid Vaccine
Freeze Dried Vaccine
Duct

By Disease Type

Newcastle Disease
Marek's Disease
Infectious Bronchitis
Infectious Bursal Disease
Others

By Application

Breeder
Broiler
Layer

By End User

Hospitals
Poultry Vaccination Centres
Poultry Firms
COMPANIES PROFILED
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Dechra Pharmaceuticals
Phibro Animal Health
Hester Biosciences
Novartis Animal Health
Ceva Sante Animale
Venky's India Ltd.
The above list can be customized.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . POULTRY VACCINES INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Disease Type
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers

5. MARKETING CHANNEL

5.1. Direct Marketing
5.2. Indirect Marketing
5.3. Marketing Channel Development Trend

6 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Broiler Historic and Forecast Sales by Regions
6.5 Layer Historic and Forecast Sales by Regions
6.6 Breeder Historic and Forecast Sales by Regions

7 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY PRODUCT

7.1 Overview by Product
7.2 Historical and Forecast Data
7.3 Analysis by Product
7.4 Attenuated Live Vaccines Historic and Forecast Sales by Regions
7.5 Inactivated Vaccines Historic and Forecast Sales by Regions
7.6 Subunit Vaccines Historic and Forecast Sales by Regions
7.7 DNA Vaccines Historic and Forecast Sales by Regions
7.8 Recombinant Vaccines Historic and Forecast Sales by Regions

8 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY DISEASE TYPE

8.1 Overview by Disease Type
8.2 Historical and Forecast Data
8.3 Analysis by Disease Type
8.4 Infectious Bronchitis Historic and Forecast Sales by Regions
8.5 Infectious Bursal Diseases Historic and Forecast Sales by Regions
8.6 Infectious Laryngotracheitis Historic and Forecast Sales by Regions
8.7 Egg Drop Syndrome Historic and Forecast Sales by Regions
8.8 Adenovirus Historic and Forecast Sales by Regions
8.9 Duck Viral Enteritis Historic and Forecast Sales by Regions
8.10 Inclusion Body Hepatitis Historic and Forecast Sales by Regions
8.11 Coccidiosis Historic and Forecast Sales by Regions
8.12 Avian Influenza Historic and Forecast Sales by Regions
8.13 Marek's Disease Historic and Forecast Sales by Regions
8.14 Newcastle Disease Historic and Forecast Sales by Regions
8.15 Salmonella Historic and Forecast Sales by Regions
8.16 Avian Encephalomyelitis Historic and Forecast Sales by Regions
8.17 Fowl Cholera Historic and Forecast Sales by Regions

9 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East Africa by Segment Sales Analysis
- 9.7.3. Middle East Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE POULTRY VACCINES COMPANIES

10.1. Poultry Vaccines Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF POULTRY VACCINES INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Boehringer Ingelheim International GmbH
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Ceva
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Zoetis
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Elanco
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Intervet Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Merck Co. Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Hester Biosciences Limited
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Vaxxinova International BV
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Venkys India
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Calier
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. KM Biologics
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Phibro Animal Health Corporation
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments